Articles for Business
June 30, 2016 | AJMC Staff
What we're reading, June 30, 2016: concerns over Anthem-Cigna deal may mean the government moves to block the merger; why the price of childhood vaccines is actually too low; and saturated fats are not as bad as once thought.
June 29, 2016 | Laura Joszt
When the topic of affordability of healthcare comes up, people usually mean the price of healthcare, but there is a difference, said Tomas Philipson, PhD, of the University of Chicago, at the ISPOR Annual Meeting.
June 28, 2016 | AJMC Staff
What we're reading, June 28, 2016: Illinois approves Aetna-Humana merger; Harvard Pilgrim Health Care reaches value-based payment agreements with Novartis and Eli Lilly; and the Supreme Court struck down key aspects of the Texas abortion law.
June 28, 2016 |
In order to get physicians engaged and involved in accountable care organizations (ACOs), it is important to educate them on the mission and understand that the organization is looking to improve, not ration, care, Stephen Nuckolls, CEO of Coastal Carolina Quality Care, explained at the National Association of Accountable Care Organizations Spring 2016 Conference.
June 27, 2016 | Laura Joszt
The rising cost of drugs is a cause for concern among various stakeholders in healthcare, some of who worry that staying on the current trajectory will “break the bank,” said panelists during a session at the ISPOR Annual Meeting.
June 27, 2016 | Surabhi Dangi-Garimella, PhD
Six former FDA commissioners participated in a discussion at the Aspen Ideas Festival on the challenges that the agency faces and whether it is well equipped to do its job.
June 26, 2016 | Jackie Syrop
More than 58% of healthcare payers’ businesses have already shifted to full value-based reimbursement models, a 10% increase since 2014.
June 25, 2016 |
This week in managed care, the top stories included House Republicans' new plan to repeal and replace the Affordable Care Act, new funding from HHS to help small practices follow the Medicare Access and CHIP Reauthorization Act, and the Supreme Court rules on a patent lawsuit that impacts pharmaceutical companies.